BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29133569)

  • 1. Efficacy of Tilorone Dihydrochloride against Ebola Virus Infection.
    Ekins S; Lingerfelt MA; Comer JE; Freiberg AN; Mirsalis JC; O'Loughlin K; Harutyunyan A; McFarlane C; Green CE; Madrid PB
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repurposing Quinacrine against Ebola Virus Infection
    Lane TR; Comer JE; Freiberg AN; Madrid PB; Ekins S
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31307979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyronaridine tetraphosphate efficacy against Ebola virus infection in guinea pig.
    Lane TR; Massey C; Comer JE; Freiberg AN; Zhou H; Dyall J; Holbrook MR; Anantpadma M; Davey RA; Madrid PB; Ekins S
    Antiviral Res; 2020 Sep; 181():104863. PubMed ID: 32682926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing Pyramax®, quinacrine and tilorone as treatments for Ebola virus disease.
    Lane TR; Dyall J; Mercer L; Goodin C; Foil DH; Zhou H; Postnikova E; Liang JY; Holbrook MR; Madrid PB; Ekins S
    Antiviral Res; 2020 Oct; 182():104908. PubMed ID: 32798602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys.
    Warren TK; Jordan R; Lo MK; Ray AS; Mackman RL; Soloveva V; Siegel D; Perron M; Bannister R; Hui HC; Larson N; Strickley R; Wells J; Stuthman KS; Van Tongeren SA; Garza NL; Donnelly G; Shurtleff AC; Retterer CJ; Gharaibeh D; Zamani R; Kenny T; Eaton BP; Grimes E; Welch LS; Gomba L; Wilhelmsen CL; Nichols DK; Nuss JE; Nagle ER; Kugelman JR; Palacios G; Doerffler E; Neville S; Carra E; Clarke MO; Zhang L; Lew W; Ross B; Wang Q; Chun K; Wolfe L; Babusis D; Park Y; Stray KM; Trancheva I; Feng JY; Barauskas O; Xu Y; Wong P; Braun MR; Flint M; McMullan LK; Chen SS; Fearns R; Swaminathan S; Mayers DL; Spiropoulou CF; Lee WA; Nichol ST; Cihlar T; Bavari S
    Nature; 2016 Mar; 531(7594):381-5. PubMed ID: 26934220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin.
    Covés-Datson EM; Dyall J; DeWald LE; King SR; Dube D; Legendre M; Nelson E; Drews KC; Gross R; Gerhardt DM; Torzewski L; Postnikova E; Liang JY; Ban B; Shetty J; Hensley LE; Jahrling PB; Olinger GG; White JM; Markovitz DM
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007595. PubMed ID: 31356611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral effect of ranpirnase against Ebola virus.
    Hodge T; Draper K; Brasel T; Freiberg A; Squiquera L; Sidransky D; Sulley J; Taxman DJ
    Antiviral Res; 2016 Aug; 132():210-8. PubMed ID: 27350309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques.
    Guedj J; Piorkowski G; Jacquot F; Madelain V; Nguyen THT; Rodallec A; Gunther S; Carbonnelle C; Mentré F; Raoul H; de Lamballerie X
    PLoS Med; 2018 Mar; 15(3):e1002535. PubMed ID: 29584730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tilorone: a Broad-Spectrum Antiviral Invented in the USA and Commercialized in Russia and beyond.
    Ekins S; Lane TR; Madrid PB
    Pharm Res; 2020 Mar; 37(4):71. PubMed ID: 32215760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing Antiviral Countermeasures Using Mouse Models of Ebolavirus Infection.
    Kroeker A; Griffin BD; Qiu X; Kobinger G
    Methods Mol Biol; 2017; 1628():273-282. PubMed ID: 28573628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a broad-spectrum antiviral with activity against Ebola virus.
    Aman MJ; Kinch MS; Warfield K; Warren T; Yunus A; Enterlein S; Stavale E; Wang P; Chang S; Tang Q; Porter K; Goldblatt M; Bavari S
    Antiviral Res; 2009 Sep; 83(3):245-51. PubMed ID: 19523489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tilorone, a Broad-Spectrum Antiviral for Emerging Viruses.
    Ekins S; Madrid PB
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32205350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-γ Inhibits Ebola Virus Infection.
    Rhein BA; Powers LS; Rogers K; Anantpadma M; Singh BK; Sakurai Y; Bair T; Miller-Hunt C; Sinn P; Davey RA; Monick MM; Maury W
    PLoS Pathog; 2015; 11(11):e1005263. PubMed ID: 26562011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Activity of Lamivudine and Zidovudine against Ebola Virus.
    Cong Y; Dyall J; Hart BJ; DeWald LE; Johnson JC; Postnikova E; Zhou H; Gross R; Rojas O; Alexander I; Josleyn N; Zhang T; Michelotti J; Janosko K; Glass PJ; Flint M; McMullan LK; Spiropoulou CF; Mierzwa T; Guha R; Shinn P; Michael S; Klumpp-Thomas C; McKnight C; Thomas C; Eakin AE; O'Loughlin KG; Green CE; Catz P; Mirsalis JC; Honko AN; Olinger GG; Bennett RS; Holbrook MR; Hensley LE; Jahrling PB
    PLoS One; 2016; 11(11):e0166318. PubMed ID: 27902714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of lethal Ebola virus infection in mice with a single dose of an S-adenosyl-L-homocysteine hydrolase inhibitor.
    Bray M; Driscoll J; Huggins JW
    Antiviral Res; 2000 Feb; 45(2):135-47. PubMed ID: 10809022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput drug screening using the Ebola virus transcription- and replication-competent virus-like particle system.
    Lee N; Shum D; König A; Kim H; Heo J; Min S; Lee J; Ko Y; Choi I; Lee H; Radu C; Hoenen T; Min JY; Windisch MP
    Antiviral Res; 2018 Oct; 158():226-237. PubMed ID: 30149038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Small Molecule Entry Inhibitors of Ebola Virus.
    Basu A; Mills DM; Mitchell D; Ndungo E; Williams JD; Herbert AS; Dye JM; Moir DT; Chandran K; Patterson JL; Rong L; Bowlin TL
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S425-34. PubMed ID: 26206510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second generation of diazachrysenes: Protection of Ebola virus infected mice and mechanism of action.
    Selaković Ž; Tran JP; Kota KP; Lazić M; Retterer C; Besch R; Panchal RG; Soloveva V; Sean VA; Jay WB; Pavić A; Verbić T; Vasiljević B; Kuehl K; Duplantier AJ; Bavari S; Mudhasani R; Šolaja BA
    Eur J Med Chem; 2019 Jan; 162():32-50. PubMed ID: 30408747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
    Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model.
    Oestereich L; Lüdtke A; Wurr S; Rieger T; Muñoz-Fontela C; Günther S
    Antiviral Res; 2014 May; 105():17-21. PubMed ID: 24583123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.